Weyland W, Weyland A, Fritz U, Redecker K, Ensink F B, Braun U
Department of Anaesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Germany.
Intensive Care Med. 1994;20(1):51-7. doi: 10.1007/BF02425058.
A paediatric option for the measurement of VO2 and VCO2 (20 to 150 ml/min) has recently been introduced for the adult Deltatrac metabolic monitor (Datex Instrumentarium, Finland) to use in ventilated and spontaneously breathing children. This paper describes a laboratory validation of the paediatric option for ventilated children with regard to the influence of respiratory variables.
Respiratory variables were varied within the following ranges: FIO2 0.21-0.8, FIO2-FEO2 (DFO2) 0.01-0.05, FECO2 0.01-0.05, VE 300-6000 ml/min, VT 8-300 ml, RR 10-50/min, P(aw) 10-60 mbar, relative humidity 10% and 60%, and resulted in 107 test situations.
Gas exchange was simulated by injection of nitrogen and CO2 at a RQ close to 1.
Different situations of paediatric patients ventilated in controlled mode were simulated on a gas injection model.
Respiratory and metabolic variables were varied independently to result in a range of 8 to 210 ml/min of VO2 and VCO2.
Reference measurements were carried out by mass spectrometry and wet gas spirometry. The mean VCO2 difference for all tests ranging from 20 ml/min to 210 ml/min was -2.4% (2SD = +/- 12%). The respective VO2 difference was -3.2% (2SD = +/- 23%). Measurement agreement for VO2 in neonatal respirator treatment (20-50 ml/min) compared to older children (50-210 ml/min) showed a mean difference of -3.9% (2SD = +/- 26%) versus -2.8% (2SD = +/- 20%). The respective differences for VCO2 were -7.1% (2SD = +/- 7%) versus +0.4% (2SD = +/- 10%). The mean difference for VO2 as well as VCO2 indicated a high systematic agreement of both methods. The variability (+/- 2SD) in VCO2 measurement is acceptable for all applications. The overall variability in VO2 measurement (2SD = +/- 23%) can be reduced by exclusion of all tests with a FECO2 and DFO2 below 0.03. This results in a mean difference of -3.2% (2SD = +/- 13.7%).
Within this limitation the paediatric measurement option seems to introduce a valuable method for clinical application in paediatric intensive care medicine.
最近为芬兰 Datex Instrumentarium 公司生产的成人 Deltatrac 代谢监测仪引入了一种用于测量 20 至 150 毫升/分钟的 VO₂ 和 VCO₂ 的儿科选项,以便用于通气和自主呼吸的儿童。本文描述了针对通气儿童的儿科选项在呼吸变量影响方面的实验室验证。
呼吸变量在以下范围内变化:吸入氧分数(FIO₂)0.21 - 0.8,吸入与呼出氧分数差值(FIO₂ - FEO₂,即 DFO₂)0.01 - 0.05,呼出二氧化碳分数(FECO₂)0.01 - 0.05,每分钟静息通气量(VE)300 - 6000 毫升,潮气量(VT)8 - 300 毫升,呼吸频率(RR)10 - 50 次/分钟,气道压(P(aw))10 - 60 毫巴,相对湿度 10%和 60%,共产生 107 种测试情况。
通过注入氮气和二氧化碳模拟气体交换,呼吸商(RQ)接近 1。
在气体注入模型上模拟了处于控制模式通气的儿科患者的不同情况。
呼吸和代谢变量独立变化,以使 VO₂ 和 VCO₂ 的范围为 8 至 210 毫升/分钟。
通过质谱分析和湿式气体体积描记法进行参考测量。所有测试中,VCO₂ 从 20 毫升/分钟到 210 毫升/分钟的平均差值为 -2.4%(2 标准差 = ±12%)。相应的 VO₂ 差值为 -3.2%(2 标准差 = ±23%)。与大龄儿童(50 - 210 毫升/分钟)相比,新生儿呼吸机治疗(20 - 50 毫升/分钟)中 VO₂ 的测量一致性显示平均差值为 -3.9%(2 标准差 = ±26%),而大龄儿童为 -2.8%(2 标准差 = ±20%)。VCO₂ 的相应差值分别为 -7.1%(2 标准差 = ±7%)和 +0.4%(2 标准差 = ±10%)。VO₂ 和 VCO₂ 的平均差值表明两种方法具有高度的系统一致性。VCO₂ 测量的变异性(±2 标准差)在所有应用中都是可接受的。通过排除所有 FECO₂ 和 DFO₂ 低于 0.03 的测试,VO₂ 测量的总体变异性(2 标准差 = ±23%)可以降低。这导致平均差值为 -3.2%(2 标准差 = ±13.7%)。
在此限制范围内,儿科测量选项似乎为儿科重症监护医学的临床应用引入了一种有价值的方法。